- Filed
- Feb 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 18, 2025 | 48.72M sh |
| Short Term Investments | FY 2024 · Dec 31, 2024 | $0 |
| Short Term Investments restated | FY 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $296.87M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $89.22M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $510.97M |
| Current Assets | FY 2024 · Dec 31, 2023 | $427.32M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.46B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 46.19M sh |
| Capex | FY 2024 · Dec 31, 2022 | $230.07M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$43.23M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.29 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.29 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $238.02M |
| Net Income | FY 2024 · Dec 31, 2022 | −$59.49M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$51.98M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $186.03M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $409.31M |
| Revenue | FY 2024 · Dec 31, 2022 | $595.34M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $719.75M |